Cartesian Therapeutics
RNAC
RNAC
59 hedge funds and large institutions have $105M invested in Cartesian Therapeutics in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
59
Holding in Top 10
1
Calls
–
Puts
$2K
Top Buyers
| 1 | +$1.79M | |
| 2 | +$1.27M | |
| 3 | +$693K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$509K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$421K |
Top Sellers
| 1 | -$2.8M | |
| 2 | -$2.24M | |
| 3 | -$1.94M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.75M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$982K |